High hepatitis E virus prevalence in pig slurry samples from the north-western region of Germany
Hinte F, Lütgehetmann M, Meister T, Giersch K, Dandri M, Wiesch J, Pischke S
ONE HEALTH-AMSTERDAM. 2026;22:101291.

Five-Year German PrEP cohort reveals high HIV protection and persistent STI burden: implications for individualized and flexible prevention strategies
Almahfoud M, Weimann L, Schäfer G, Koch T, Matthews H, Weichel H, Hunstig F, Grenz M, Scheiter R, Addo M, Schulze Zur Wiesch J, Degen O
INFECTION. 2025 [Epub ahead of print].

Clinical standards for antimicrobial stewardship in TB care
Brehm T, Akkerman O, Sotgiu G, Tiberi S, Chang K, Dheda K, Duarte R, Vambe D, Udwadia Z, Chesov D, Mendelson M, Iswari Saktiawati A, van Ingen J, Eyuboglu F, Tängdén T, Quang Vo L, Riccardi N, Moschos C, Friedland J, Lillebaek T, Chandy S, Caminero J, Thwaites G, Gandra S, Thursky K, George I, Konstantynovska O, Fatima R, Yim J, Kwak N, Olaru I, Gillespie S, Kherabi Y, Perl S, Grønningen E, Rodrigues C, Bjerrum S, Bange F, Cox V, Cirillo D, Saluzzo F, Hara G, Wagner D, Ismail N, Sloan D, Eshun-Wilsonova I, Zeng M, Cantero C, Vasankari T, Mandalakas A, Kay A, Ness T, Torrico M, Günther G, Kuksa L, Guglielmetti L, García-Basteiro A, Marks G, Pulcini C, Lange C
IJTLD open. 2025;2(12):716-726.

High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered?
Brehm T, Köhler N, Grobbel H, Welling J, Mandalakas A, Fava V, Schurr E, Lange C
INFECTION. 2025;53(4):1501-1506.

The influence of cell culture media and their additives on virus inactivation in vitro
Brill F, Becker B, Paulmann D, Bischoff B, Herrmann A, Meister T, Steinmann E, Steinmann J, Konrat K
GMS HYG INFECT CONTR. 2025;20:.

JNK kinase regulates phosphorylation of HCoV-229E nucleocapsid protein
Brüggemann Y, Meister T, Heinen N, Richter E, Westhoven S, Poppe M, Shaban M, Sirkinti L, Nocke M, Todt D, Pfaender S, Kracht M, Steinmann E
Npj viruses. 2025;3(1):.

Experimental Infection of Mice with the Parasitic Nematode Strongyloides ratti
Dörken S, Duhm K, Viebrock B, Linnemann L, Heepmann L, Hartmann W, Antwi-Ekwuruke J, Yunus M, Breloer M
JOVE-J VIS EXP. 2025;(215):.

Melioidosis imported to Northern Germany: a case report series
Ekoka Mbassi D, Abdelrahim A, Grewe I, Michelitsch P, Hennigs A, Olearo F, Addo M, Ramharter M, Jordan S, Schmiedel S
INFECTION. 2025 [Epub ahead of print];1-10.

Newly identified properties of known pharmaceuticals and myxobacterial small molecules revealed by screening for autophagy modulators
Fichtner J, Beer Y, Ramm H, Mühlen S, Surup F, Herrmann J, Meister T, Pfaender S, Bilitewski U, Brönstrup M, Müller R, Wirth M, Eskelinen E, Schmitz I
FEBS J. 2025 [Epub ahead of print].

Susceptibility of Measles Virus to World Health Organization-Recommended Hand Rubs, Oral Rinses, and Surface Disinfectants
Flores L, Addo M, Steinmann E, Meister T
OPEN FORUM INFECT DI. 2025;12(11):.

A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patients
Gorgulho J, Trenkner T, Kinkel E, Fritzsche B, Kachel P, Peine S, Matschl U, Altfeld M, Huber S, Lohse A, Alsdorf W, Bokemeyer C, Hoelzemer A, Beltran W, von Felden J
ONCOIMMUNOLOGY. 2025;14(1):.

Melioidosis clinically unresponsive to meropenem in a traveller returning from Thailand
Grewe I, Hennigs A, Olearo F, Addo M, Ramharter M, Jordan S
IDCASES. 2025;42:e02407.

Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes
Hamann M, Godbole S, Adiba M, Leddy S, Navolić J, Tabatabai G, Merk D, Lange U, Neumann J
ACTA NEUROPATHOL COM. 2025;13(1):.

Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection
Hardtke S, Yurdaydin C, Caruntu F, Curescu M, Yalcin K, Akarca U, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis G, Port K, Manns M, Cornberg M, Kahlhöfer J, Wedemeyer H
J VIRAL HEPATITIS. 2025;32(4):.

A transatlantic joint lab model for interdisciplinary research
Hoelzemer A, Garcia-Beltran W
NAT MICROBIOL. 2025;10(10):2356-2358.

Entamoeba histolytica extracellular vesicles drive pro-inflammatory monocyte signaling
Honecker B, Bärreiter V, Höhn K, Horváth B, Harant K, Metwally N, Marggraff C, Anders J, Leyk S, Martínez-Tauler M, Bea A, Hansen C, Fehling H, Lütkemeyer M, Lorenzen S, Franzenburg S, Lotter H, Bruchhaus I
PLOS NEGLECT TROP D. 2025;19(4):.

Long-term persistence and boostability of immune responses following different rabies pre-exposure prophylaxis priming schedules of a purified chick embryo cell rabies vaccine administered alone or concomitantly with a Japanese encephalitis vaccine
Jelinek T, Schunk M, Reisinger E, Addo M, Wiedermann U, Costantini M, Lattanzi M, Pellegrini M, Galgani I
PLOS NEGLECT TROP D. 2025;19(5):.

Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe
Kirakosyan O, Reimann M, Andersen A, Bjarnason A, Bakos Á, Dyrhol-Riise A, McLaughlin A, Nita C, Pieridou D, Chesov D, Davidavičienė E, Günther G, Atshemyan H, Muylle I, Solovic I, Bruchfeld J, Manika K, Kuksa L, Codecasa L, Stosic M, Skowroński M, Makek M, Fréchet Jachym M, Knappik M, Santin M, Yatskevich N, Konstantynovska O, Akkerman O, Svetina P, Viiklepp P, Duarte R, Zeynel S, Togonidze T, Vasankari T, Parris V, Özkara Ş, Lange C, Brehm T
IJTLD open. 2025;2(2):101-106.

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab
Kocheise L, Kempski J, Tang Y, Balcar L, Berger V, Tomczak M, Gorgulho J, Masood R, Giehren F, Schmidt C, Sutter J, Fruendt T, Pagani F, Wulf S, Kött J, Domanig S, Giannou A, Bedke T, Lücke J, Zhang T, Zhang S, Machicote A, Lohse A, Alunni-Fabbroni M, Ricke J, Khaled N, Pinter M, Scheiner B, Huber S, von Felden J, Piseddu I, Schulze K
ANN HEPATOL. 2025 [Epub ahead of print];31(1):102138.

Virucidal activity of household laundry detergents and additives in simulated wash cycles
Konkol J, Becker B, Paulmann D, Steinmann E, Todt D, Meister T, Evers S, Dotzauer A, Weide M, Brill F
J APPL MICROBIOL. 2025;136(3):.

Utilization of interdisciplinary in-hospital early rehabilitation in COVID-19 patients - a multicenter cohort study in the National Pandemic Cohort Network (NAPKON) in Germany
Liebl M, Reisshauer A, Ludovici-Krug D, Baumbach P, Appel K, Blaschke S, Erber J, Grewe I, Hagen M, Heim E, Pütz S, Lehnert K, Meybohm P, Miljukov O, Milovanovic M, Nunes de Miranda S, Römmele C, Tepasse P, Vehreschild J, Weinert N, Weigl M, Wendel J, Lemhöfer C
PLOS ONE. 2025;20(10):e0334941.

Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants
Meister T, Nocke M, Heinen N, Burkard T, Brüggemann Y, Westhoven S, Trüeb B, Ebert N, Thomann L, Lubieniecki K, Lubieniecka J, Döring K, Herrmann M, Haid S, Pietschmann T, Wiegmann B, Tao R, Pfefferle S, Addo M, Thiel V, Drexler I, Babel N, Phuc Nguyen H, Brown R, Todt D, Steinmann E, Pfaender S
P NATL ACAD SCI USA. 2025;122(28):e2500276122.

Standing on the shoulders of giants - virtue and vulnerability in science
Mellinghoff S, Alessandra A, Assion Y, Cornely O, Addo M, Bloeser C
CLIN MICROBIOL INFEC. 2025;31(12):1958-1960.

Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD-1 Inhibition as Potential Treatment Option
Mellinghoff S, Thelen M, von Bergwelt-Baildon M, Schlößer H, Cornely O, Sprute R, Stemler J, Mayer L, Weskamm M, Friedrich M, Ly M, Dahlke C, Addo M
MYCOSES. 2025;68(3):.

HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine production
Mensching L, Beiersdorfer M, Schloer S, Köllmann S, Reinsberg F, Padoan B, Fittje P, Trenkner T, Zaayenga A, Martrus G, Almahfoud M, Stürzel C, Sauter D, Kirchhoff F, Schulze Zur Wiesch J, Altfeld M, Garcia-Beltran W, Hoelzemer A
ISCIENCE. 2025;28(7):112879.

The Influence of Climate Change on Vector-Borne Diseases in a Wilderness Medicine Context
Mertens J
WILD ENVIRON MED. 2025;36(1):44-60.

A study protocol for neonatal sepsis and gut microbiomics among preterm infants admitted at Muhimbili National Hospital, Tanzania
Mussa F, Joachim A, Moshiro R, Masoud S, Addo M, Pagel J, Krumkamp R, Kobbe R, Salim N
PLOS ONE. 2025;20(6):.

Stability of Andes virus and its inactivation by WHO-recommended hand rub formulations and surface disinfectants
Nilsson-Payant B, Dafi R, Krüger S, Rosenthal M, Todt D, Addo M, Steinmann E, Meister T
J HOSP INFECT. 2025;166:5-11.

Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease
Olal C, Bodmer B, Rottstegge M, Escudero-Pérez B, Port J, Bencsik A, Nelson E, Heung M, Wurr S, Blake O, Adam E, Oestereich L, Baz-Martínez M, Müller-Guhl J, Gallais Y, Anjuère F, Malliere B, Idoyaga J, Hoenen T, Muñoz-Fontela C
J INFECT DIS. 2025;231(4):e615-e625.

Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
Raadsen M, Dahlke C, Fathi A, Hardtke S, Klüver M, Krähling V, Gerresheim G, Mayer L, Mykytyn A, Weskamm L, Zoran T, van Gorp E, Sutter G, Becker S, Haagmans B, Addo M
LANCET INFECT DIS. 2025;25(2):231-242.

Performance of whole blood interferon-γ release assays in SARS-CoV-2 and tuberculosis is age dependent
Rothoeft T, Hoffmann A, Maier C, Denz R, Kobbe R, Friedrichs A, Behrens G, Behrens P, Berner R, Caliebe A, Denkinger C, Giesbrecht K, Hojenski L, Hovardovska O, Dopfer-Jablonka A, Iatseniuk O, Kaasch A, Kraus M, Mitrov L, Nauck M, de Miranda S, Scherer M, Schmiedel Y, Stahl D, Timmesfeld N, Toepfner N, Vehreschild J, Wohlgemuth W, Petersmann A, Vehreschild M, Brinkmann F
INFECTION. 2025;53(6):2669-2680.

From skin lesions to multi-organ involvement: Organ tropism and pathogenesis of mpox virus
Rupp A, Meister J, Wiesch J, Meister T
ISCIENCE. 2025;28(12):114209.

Harnessing innate immunity: natural killer cells and innate immune responses in reservoir clearance
Schiering K, Beiersdorfer M, Hoelzemer A
CURR OPIN HIV AIDS. 2025;20(6):552-558.

Caseload, clinical spectrum and economic burden of infectious diseases in patients discharged from hospitals in Germany
Stocker H, Kron F, Hartmann P, de With K, Addo M, Vehreschild M, Fätkenheuer G, Salzberger B, Sander L, Rupp J
INFECTION. 2025;53(5):1863-1873.

Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
White E, Kityo C, Spyer M, Mujuru H, Nankya I, Kekitiinwa A, Lugemwa A, Kaudha E, Liberty A, Cassim H, Archary M, Cotton M, Ahimbisibwe G, Cressey T, Ngampiyaskul C, Srirompotong U, Behuhuma O, Saidi Y, Bamford A, Kobbe R, Nastouli E, Rojo P, Giaquinto C, Gibb D, Ford D, Turkova A
LANCET HIV. 2025;12(3):e201-e213.

Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women
Wiemers P, Graf I, Addo M, Arck P, Diemert A
SEMIN IMMUNOPATHOL. 2025;47(1):25.

Non-invasive diagnosis of pulmonary tuberculosis using face mask sampling: A prospective study in adults
Woelk D, Meiwes L, Ciobanu N, Crudu V, Comanac A, Kulcitkaia S, Vasiliu A, Mandalakas A, Lange C, Brehm T, Chesov D
CLIN MICROBIOL INFEC. 2025 [Epub ahead of print].

Analysis of gene expression in patients prior to TB treatment to identify those associated with pyrazinamide-hepatotoxicity
Zielinski N, Brehm T, Köhler N, Sánchez Carballo P, Schaub D, Lange C, Reimann M
IJTLD open. 2025;2(8):497-499.

Management and outcome of cutaneous diphtheria in adolescent refugees in Germany, June 2022 - October 2023
Zink A, Hofer J, Schneider C, Kessler F, Klenze H, Klauwer D, Maleki K, Müller A, Goretzki S, Wang S, Kobbe R, Ramirez A, Bode S, Janda A, Fressle R, Remppis J, Henneke P, Rieg S, Berger A, Sing A, Hufnagel M, Spielberger B
INFECTION. 2025;53(1):329-337.

S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

Z GASTROENTEROL. 2024;62(7):1090-1149.

Invasive Pilzinfektionen: Herausforderungen und aktuelle Entwicklungen
Addo M
DEUT MED WOCHENSCHR. 2024;149(10):541.

„Superbugs“: Epidemiologie und Behandlung multiresistenter Bakterien
Addo M
DEUT MED WOCHENSCHR. 2024;149(19):1119-1120.

RSV vaccination strategies for high-risk patients 2023: a collaborative position paper by leading German medical societies and organizations
Addo M, Cornely O, Denkinger M, Ertl G, Herold S, Pletz M, Rohde G, Welte T, Windisch W, Witzenrath M
INFECTION. 2024;52(1):285-288.

Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D
Anastasiou O, Caruntu F, Curescu M, Yalcin K, Akarca U, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis G, Keskin O, Port K, Radu M, Celen M, Idilman R, Heidrich B, Mederacke I, von der Leyen H, Kahlhöfer J, von Karpowitz M, Hardtke S, Cornberg M, Yurdaydin C, Wedemeyer H
LIVER INT. 2024;44(1):139-147.

Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)
Appel K, Nürnberger C, Bahmer T, Förster C, Polidori M, Kohls M, Kraus T, Hettich-Damm N, Petersen J, Blaschke S, Bröhl I, Butzmann J, Dashti H, Deckert J, Dreher M, Fiedler K, Finke C, Geisler R, Hanses F, Hopff S, Jensen B, Konik M, Lehnert K, de Miranda S, Mitrov L, Miljukov O, Reese J, Rohde G, Scherer M, Tausche K, Tebbe J, Vehreschild J, Voit F, Wagner P, Weigl M, Lemhöfer C
INFECTION. 2024;52(5):1813-1829.

Renal implications of coronavirus disease 2019: insights into viral tropism and clinical outcomes
Bärreiter V, Meister T
CURR OPIN MICROBIOL. 2024;79:.

(Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review
Brehm T, Reimann M, Köhler N, Lange C
CLIN MICROBIOL INFEC. 2024;30(8):989-998.

Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM)
Brinkmann F, Friedrichs A, Behrens G, Behrens P, Berner R, Caliebe A, Denkinger C, Giesbrecht K, Gussew A, Hoffmann A, Hojenski L, Hovardovska O, Dopfer-Jablonka A, Kaasch A, Kobbe R, Kraus M, Lindner A, Maier C, Mitrov L, Nauck M, de Miranda S, Scherer M, Schmiedel Y, Stahl D, Timmesfeld N, Toepfner N, Vehreschild J, Wohlgemuth W, Petersmann A, Vehreschild M
J INFECT PUBLIC HEAL. 2024;17(4):642-649.

Epidemiology of 7375 children and adolescents hospitalized with COVID-19 in Germany, reported via a prospective, nationwide surveillance study in 2020-2022
Doenhardt M, Hufnagel M, Diffloth N, Hübner J, Mauer R, Schneider D, Simon A, Tenenbaum T, Trotter A, Armann J, Berner R
SCI REP-UK. 2024;14(1):47.

SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition
Fischer C, Willscher E, Paschold L, Gottschick C, Klee B, Diexer S, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, Hoell J, Gekle M, Addo M, Schulze Zur Wiesch J, Mikolajczyk R, Binder M, Schultheiß C
NPJ VACCINES. 2024;9(1):23.

MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity
Grewe I, Friedrich M, Dieck M, Spohn M, Ly M, Krähling V, Mayer L, Mellinghoff S, Rottstegge M, Kraemer R, Volz A, Becker S, Fathi A, Dahlke C, Weskamm L, Addo M
FRONT IMMUNOL. 2024;15:.

Identification of a spike-specific CD8+ T cell epitope following vaccination against the Middle East respiratory syndrome coronavirus in humans
Harrer C, Mayer L, Fathi A, Lassen S, Ly M, Zinser M, Wolf T, Becker S, Sutter G, Dahlke C, Addo M
J INFECT DIS. 2024;230(2):e327-e332.

Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
Hartmann J, Cardoso M, Talarico M, Kenney D, Leone M, Reese D, Turcinovic J, O'Connell A, Gertje H, Marino C, Ojeda P, De Paula E, Orsi F, Velloso L, Cafiero T, Connor J, Ploss A, Hoelzemer A, Carrington M, Barczak A, Crossland N, Douam F, Boucau J, Garcia-Beltran W
CELL. 2024;187(10):2393-2410.e14.

Health and socio-demographic background of Ukrainian minors and their families in Germany - challenges for refugee medicine: A cross-sectional study from the German Network University Medicine (NUM)
Hoffmann A, Kobbe R, Denz R, Maier C, Toepfner N, Timmesfeld N, Petersmann A, Giesbrecht K, Hovardovska O, Vehreschild J, Scherer M, de Miranda S, Mitrov L, Friedrichs A, Caliebe A, Skipiol K, Holzwarth S, Kaur Y, Schlegtendal A, Hojenski L, Ruß A, Vehreschild M, Brinkmann F
EUR J PEDIATR. 2024;184(1):64.

Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron: results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP)
Hopff S, Appel K, Miljukov O, Schneider J, Addo M, Bals R, Bercker S, Blaschke S, Bröhl I, Büchner N, Dashti H, Erber J, Friedrichs A, Geisler R, Göpel S, Hagen M, Hanses F, Jensen B, Keul M, Krawczyk A, Lorenz-Depiereux B, Meybohm P, Milovanovic M, Mitrov L, Nürnberger C, Obst W, Römmele C, Schäfer C, Scheer C, Scherer M, Schmidt J, Seibel K, Sikdar S, Tebbe J, Tepasse P, Thelen P, Vehreschild M, Weismantel C, Vehreschild J
INFECTION. 2024;52(6):2253-2267.

MicroRNAs modulate SARS-CoV-2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2
Khanal R, Heinen N, Bogomolova A, Meister T, Herrmann S, Westhoven S, Nocke M, Todt D, Jockenhövel F, Klein I, Hartmann L, Vondran F, Steinmann E, Zimmer G, Ott M, Brown R, Sharma A, Pfaender S
LIVER INT. 2024;44(11):2983-2995.

Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children
Kobbe R, Rau C, Schulze-Sturm U, Stahl F, Fonseca-Brito L, Diemert A, Lütgehetmann M, Addo M, Arck P, Weskamm L
PEDIATR INFECT DIS J. 2024;43(12):1200-1203.

Challenges in Diagnosing and Treating Acutely Febrile Children with Suspected Malaria at Health Care Facilities in the Lake Mwanza Region of Tanzania
Koliopoulos P, Kayange N, Jensen C, Gröndahl B, Eichmann J, Daniel T, Huth F, Eckert T, Klamm N, Follmann M, Medina-Montaño G, Hokororo A, Pretsch L, Klüber J, Schmidt C, Züchner A, Addo M, Okamo B, Mshana S, Gehring S
AM J TROP MED HYG. 2024;110(2):202-208.

A comprehensive approach for evaluating the virucidal performance of domestic laundry detergents under practical conditions
Konkol J, Becker B, Paulmann D, Steinmann E, Todt D, Meister T, Evers S, Weide M, Dotzauer A, Brill F
J APPL MICROBIOL. 2024;135(3):.

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates
Mayer L, Weskamm L, Addo M
SIGNAL TRANSDUCT TAR. 2024;9(1):363.

Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates
Mayer L, Weskamm L, Addo M
SIGNAL TRANSDUCT TAR. 2024;9(1):.

MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
Mayer L, Weskamm L, Fathi A, Kono M, Heidepriem J, Krähling V, Mellinghoff S, Ly M, Friedrich M, Hardtke S, Borregaard S, Hesterkamp T, Loeffler F, Volz A, Sutter G, Becker S, Dahlke C, Addo M
NPJ VACCINES. 2024;9(1):20.

Inactivation of yellow fever virus by WHO-recommended hand rub formulations and surface disinfectants
Meister T, Frericks N, Kleinert R, Rodríguez E, Steinmann J, Todt D, Brown R, Steinmann E
PLOS NEGLECT TROP D. 2024;18(6):.

Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia
Mellinghoff S, Robrecht S, Sprute R, Mayer L, Weskamm L, Dahlke C, Gruell H, Teipel F, Schlößer H, Siepmann K, Thelen M, Fink A, Fischer K, Klein F, Addo M, Kolovou A, Cornely O, Eichhorst B, Hallek M, Langerbeins P
EUR J HAEMATOL. 2024;112(5):788-793.

A History of Malaria and Conflict
Mertens J
PARASITOL RES. 2024;123(3):165.

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development
Mertens J, Rigby C, Bardelli M, Quinkert D, Hou M, Diouf A, Silk S, Chitnis C, Minassian A, Moon R, Long C, Draper S, Miura K
VACCINE. 2024;42(16):3621-3629.

Expression and localization of two β-carbonic anhydrases in Bienertia, a single-cell C4 plant
Nguyen T, Lee N, Frömling F, Meister T, Kim J, Offermann S, Hwang I
FRONT PLANT SCI. 2024;15:1506375.

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine
Odak I, Riemann L, Sandrock I, Cossmann A, Ramos G, Hammerschmidt S, Ritter C, Friedrichsen M, Hassan A, Dopfer-Jablonka A, Stankov M, Weskamm L, Addo M, Ravens I, Willenzon S, Schimrock A, Ristenpart J, Janssen A, Barros-Martins J, Hansen G, Falk C, Behrens G, Förster R
EBIOMEDICINE. 2024;99:.

Monitoring of hepatitis E virus in wastewater can identify clinically relevant variants
Rau F, Elsner C, Meister T, Gömer A, Kallies R, Dittmer U, Steinmann E, Todt D
LIVER INT. 2024;44(3):637-643.

Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID-19
Riemann L, Weskamm L, Mayer L, Odak I, Hammerschmidt S, Sandrock I, Friedrichsen M, Ravens I, Fuss J, Hansen G, Addo M, Förster R
EUR J IMMUNOL. 2024;54(11):e2451236.

Lack of evidence of acute HEV infections as a sexually transmitted disease: Data from a German cohort of PrEP users
Schäfer G, Lübke R, Degen O, Mader M, Scheiter R, Wolski A, Addo M, Schulze Zur Wiesch J, Pischke S
BRAZ J INFECT DIS. 2024;28(1):103720.

Electronic data capture in resource-limited settings using the lightweight clinical data acquisition and recording system
Vielhauer J, Mahajan U, Adorjan K, Benesch C, Oehrle B, Beyer G, Sirtl S, Johlke A, Allgeier J, Pernpruner A, Erber J, Shamsrizi P, Schulz C, Albashiti F, Hinske L, Mayerle J, Stubbe H
SCI REP-UK. 2024;14(1):.

Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
von der Schulenburg P, Behrens G, Hoffmann M, Linke A, Nehlmeier I, Kempf A, Stankov M, Lütgehetmann M, Jahnke-Triankowski J, Addo M, Fischer L, Lohse A, Pöhlmann S, Schulze Zur Wiesch J, Sterneck M
VIRUSES-BASEL. 2024;16(12):.

High vaccination coverage and infection rate result in a robust SARS-CoV-2-specific immunity in the majority of liver cirrhosis and transplant patients: A single-center cross-sectional study
von der Schulenburg P, Herting A, Harberts A, Lütgehetmann M, Jahnke-Triankowski J, Pischke S, Piecha F, Drolz A, Jörg V, Hübener P, Wehmeyer M, Addo M, Fischer L, Lohse A, Schulze Zur Wiesch J, Sterneck M
UNITED EUR GASTROENT. 2024;12(3):339-351.

Impfungen für neu- und wiederauftretende Viruserkrankungen
Weichel H, Koch T
INNERE MED. 2024;65(11):1082-1091.

Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Weskamm L, Tarnow P, Harms C, Huchon M, Raadsen M, Friedrich M, Rübenacker L, Grüttner C, Garcia M, Koch T, Becker S, Sutter G, Lhomme E, Haagmans B, Fathi A, Blois S, Dahlke C, Richert L, Addo M
ISCIENCE. 2024;27(8):110470.

Genetic determinants of host- and virus-derived insertions for hepatitis E virus replication
Wißing M, Meister T, Nocke M, Gömer A, Masovic M, Knegendorf L, Brüggemann Y, Bader V, Siddharta A, Bock C, Ploss A, Kenney S, Winklhofer K, Behrendt P, Wedemeyer H, Steinmann E, Todt D
NAT COMMUN. 2024;15(1):.

Think Tbc!: An Tuberkulose denken, rechtzeitig diagnostizieren und sachgerecht behandeln
Addo M
DEUT MED WOCHENSCHR. 2023;148(19):1213-1214.

Positionspapier zur RSV-Schutzimpfung bei besonders gefährdeten Patientinnen und Patienten der Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Addo M, Cornely O, Denkinger M, Ertl G, Herold S, Pletz M, Rohde G, Welte T, Windisch W, Witzenrath M
2023.

Comparative analysis of characteristics and outcomes in hospitalized COVID-19 patients infected with different SARS-CoV-2 variants between January 2020 and April 2022 - A retrospective single-center cohort study
Brehm T, Heyer A, Woo M, Fischer M, van der Meirschen M, Wichmann D, Jarczak D, Roedl K, Schmiedel S, Addo M, Lütgehetmann M, Christner M, Huber S, Lohse A, Kluge S, Schulze Zur Wiesch J
J INFECT PUBLIC HEAL. 2023;16(11):1806-1812.

Mini-laparoscopy as a diagnostic tool for abdominal tuberculosis: a retrospective series of 29 cases
Brehm T, Ndzedzeka-Völz N, Wehmeyer M, Christner M, Clauditz T, Hübener P, Addo M, Lohse A, Schmiedel S
SURG ENDOSC. 2023;37(3):1830-1837.

Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19
Camirand-Lemyre F, Merson L, Tirupakuzhi Vijayaraghavan B, Burrell A, Citarella B, Domingue M, Lévesque S, Usuf E, Wils E, Ohshimo S, Martin-Loeches I, Sandulescu O, Laake J, Lamontagne F
JAMA NETW OPEN. 2023;6(12):e2346502.

Neurological manifestations of COVID-19 in adults and children
Cho S, White N, Premraj L, Battaglini D, Fanning J, Suen J, Bassi G, Fraser J, Robba C, Griffee M, Singh B, Citarella B, Merson L, Solomon T, Thomson D
BRAIN. 2023;146(4):1648-1661.

Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection
Cords L, Woost R, Kummer S, Brehm T, Kluge S, Schmiedel S, Jordan S, Lohse A, Altfeld M, Addo M, Schulze Zur Wiesch J, Beisel C
CYTOKINE. 2023;162:.

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
Denkinger C, Janssen M, Schäkel U, Gall J, Leo A, Stelmach P, Weber S, Krisam J, Baumann L, Stermann J, Merle U, Weigand M, Nusshag C, Bullinger L, Schrezenmeier J, Bornhäuser M, Alakel N, Witzke O, Wolf T, Vehreschild M, Schmiedel S, Addo M, Herth F, Kreuter M, Tepasse P, Hertenstein B, Hänel M, Morgner A, Kiehl M, Hopfer O, Wattad M, Schimanski C, Celik C, Pohle T, Ruhe M, Kern W, Schmitt A, Lorenz H, Souto-Carneiro M, Gaeddert M, Halama N, Meuer S, Kräusslich H, Müller B, Schnitzler P, Parthé S, Bartenschlager R, Gronkowski M, Klemmer J, Schmitt M, Dreger P, Kriegsmann K, Schlenk R, Müller-Tidow C
NAT CANCER. 2023;4(1):96-107.

Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial
Dinkelborg K, Kahlhöfer J, Dörge P, Yurdaydin C, Hardtke S, Caruntu F, Curescu M, Yalcin K, Akarca U, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis G, Keskin O, Port K, Radu M, Celen M, Idilman R, Weber K, Stift J, Wittkop U, Heidrich B, Mederacke I, von der Leyen H, Dienes H, Cornberg M, Koch A, Manns M, Wedemeyer H, Deterding K
LIVER INT. 2023;43(8):1663-1676.

Long-Term Antibody Response to SARS-CoV-2 in Children
Dunay G, Barroso M, Woidy M, Danecka M, Engels G, Hermann K, Neumann F, Paul K, Beime J, Escherich G, Fehse K, Grinstein L, Haniel F, Haupt L, Hecher L, Kehl T, Kemen C, Kemper M, Kobbe R, Kohl A, Klokow T, Nörz D, Olfe J, Schlenker F, Schmiesing J, Schrum J, Sibbertsen F, Stock P, Tiede S, Vettorazzi E, Zazara D, Zapf A, Lütgehetmann M, Oh J, Mir T, Muntau A, Gersting S
J CLIN IMMUNOL. 2023;43(1):46-56.

High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022
Ettemeyer M, Florey M, Tanida K, Jochum J, Schulze-Sturm U, Lütgehetmann M, Baehr M, Addo M, Schmiedel S, Rohde H, Koch T
INFECTION. 2023;51(5):1569-1575.

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients
Gömer A, Klöhn M, Jagst M, Nocke M, Pischke S, Horvatits T, Schulze Zur Wiesch J, Müller T, Hardtke S, Cornberg M, Wedemeyer H, Behrendt P, Steinmann E, Todt D
HEPATOLOGY. 2023;78(6):1882-1895.

Partially Reversible Immunodeficiency After In-Utero Exposure to Immunosuppressants
Gossling K, Kobbe R, Boetticher B, Soura S, Borkhardt A, Wittkowski H, Schwab M, Kobbe G, Neubert J, Ghosh S, Laws H, Oommen P
DTSCH ARZTEBL INT. 2023;120(46):795-796.

Tecovirimat for the treatment of severe Mpox in Germany
Hermanussen L, Brehm T, Wolf T, Boesecke C, Schlabe S, Borgans F, Monin M, Jensen B, Windhaber S, Scholten S, Jordan S, Lütgehetmann M, Wiesch J, Addo M, Mikolajewska A, Niebank M, Schmiedel S
INFECTION. 2023;51(5):1563-1568.

Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern-A first case-series experience
Hermanussen L, Grewe I, Tang H, Nörz D, Bal L, Pfefferle S, Unger S, Hoffmann C, Berzow D, Kohsar M, Aepfelbacher M, Lohse A, Addo M, Lütgehetmann M, Schulze zur Wiesch J, Schmiedel S
J MED VIROL. 2023;95(1):e28181.

Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave
Herting A, Jahnke-Triankowski J, Harberts A, Schaub G, Lütgehetmann M, Ruether D, Fischer L, Addo M, Lohse A, Schulze Zur Wiesch J, Sterneck M
VIRUSES-BASEL. 2023;15(2):.

Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
Hufnagel K, Fathi A, Stroh N, Klein M, Skwirblies F, Girgis R, Dahlke C, Hoheisel J, Lowy C, Schmidt R, Griesbeck A, Merle U, Addo M, Schröder C
COMMUN MED-LONDON. 2023;3(1):51.

Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability
Huttner A, Agnandji S, Engler O, Hooper J, Kwilas S, Ricks K, Clements T, Jonsdottir H, Nakka S, Rothenberger S, Kremsner P, Züst R, Medaglini D, Ottenhoff T, Harandi A, Siegrist C
CLIN MICROBIOL INFEC. 2023;29(12):1587-1594.

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C, Baillie J, Barrio N, Baruch J, Beane A, Blumberg L, Bozza F, Broadley T, Burrell A, Carson G, Citarella B, Dagens A, Dankwa E, Donnelly C, Dunning J, Elotmani L, Escher M, Farshait N, Goffard J, Gonçalves B, Hall M, Hashmi M, Sim Lim Heng B, Ho A, Jassat W, Pedrera Jiménez M, Laouenan C, Lissauer S, Martin-Loeches I, Mentré F, Merson L, Morton B, Munblit D, Nekliudov N, Nichol A, Singh Oinam B, Ong D, Panda P, Petrovic M, Pritchard M, Ramakrishnan N, Ramos G, Roger C, Sandulescu O, Semple M, Sharma P, Sigfrid L, Somers E, Streinu-Cercel A, Taccone F, Vecham P, Kumar Tirupakuzhi Vijayaraghavan B, Wei J, Wils E, Ci Wong X, Horby P, Rojek A, Olliaro P
INT J EPIDEMIOL. 2023;52(2):355-376.

Reduced Humoral and Cellular Immune Response to Primary COVID-19 mRNA Vaccination in Kidney Transplanted Children Aged 5–11 Years
Lalia J, Schild R, Lütgehetmann M, Dunay G, Kallinich T, Kobbe R, Massoud M, Oh J, Pietzsch L, Schulze-Sturm U, Schuetz C, Sibbertsen F, Speth F, Thieme S, Witkowski M, Berner R, Muntau A, Gersting S, Toepfner N, Pagel J, Paul K
VIRUSES-BASEL. 2023;15(7):1553.

History of cerebrovascular disease but not dementia increases the risk for secondary vascular events during SARS-CoV-2 infection with presumed Omicron variant: a retrospective observational study
Mayer C, Woo M, Brehm T, Heyer A, Fischer M, Fischbach F, Bal L, Addo M, Kluge S, Thomalla G, Schweingruber N, Wiesch J
EUR J NEUROL. 2023;30(8):2297-2304.

β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training
Pilchová V, Prajeeth C, Jendrny P, Twele F, Meller S, Pink I, Fathi A, Addo M, Volk H, Osterhaus A, von Köckritz-Blickwede M, Schulz C
J VIROL METHODS. 2023;317:.

Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein
Raadsen M, Dahlke C, Fathi A, Lamers M, van den Doel P, Zaeck L, van Royen M, de Bruin E, Sikkema R, Koopmans M, van Gorp E, Sutter G, de Vries R, Addo M, Haagmans B
J INFECT DIS. 2023;228(5):586-590.

Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series
Rau C, Auer-Hackenberg L, Deubzer H, Schwabel E, Jaros M, Diederichs A, Lehrnbecher T, Holm M, von Linstow M, Martin L, Dinges S, Rothensteiner M, Siepermann M, Strenger V, von Both U, Teig N, Brinkmann F, Leeb F, Zeitlinger M, Kobbe R, Götzinger F
PEDIATR INFECT DIS J. 2023;42(2):125-129.

Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry
Rojas-Restrepo J, Sindram E, Zenke S, Haberstroh H, Mitsuiki N, Gabrysch A, Huebscher K, Posadas-Cantera S, Krausz M, Kobbe R, Rohr J, Grimbacher B, Gamez-Diaz L
J CLIN IMMUNOL. 2023;43(8):2090.

Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
Rojas-Restrepo J, Sindram E, Zenke S, Haberstroh H, Mitsuiki N, Gabrysch A, Huebscher K, Posadas-Cantera S, Krausz M, Kobbe R, Rohr J, Grimbacher B, Gámez-Díaz L
J CLIN IMMUNOL. 2023;43(8):2076-2089.

Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort
Shah N, Xue B, Xu Z, Yang H, Marwali E, Dalton H, Payne P, Lu C, Said A
ARTIF ORGANS. 2023;47(9):1490-1502.

Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort
Shi Y, Strobl R, Apfelbacher C, Bahmer T, Geisler R, Heuschmann P, Horn A, Hoven H, Keil T, Krawczak M, Krist L, Lemhöfer C, Lieb W, Lorenz-Depiereux B, Mikolajczyk R, Montellano F, Reese J, Schreiber S, Skoetz N, Störk S, Vehreschild J, Witzenrath M, Grill E
INFECTION. 2023;51(6):1679-1694.

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
Turkova A, White E, Kekitiinwa A, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe G, Moloantoa T, Srirompotong U, Mosia N, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi M, Klein N, Mujuru H, Kityo C, Cotton M, Ferrand R, Giaquinto C, Rojo P, Violari A, Gibb D, Ford D
LANCET CHILD ADOLESC. 2023;7(10):718-727.

Mpox: evaluation of immune responses induced after infection versus vaccination
Weichel H
2023. DZIF Annual Meeting 2023. .

Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses
Westphal T, Mader M, Karsten H, Cords L, Knapp M, Schulte S, Hermanussen L, Peine S, Ditt V, Grifoni A, Addo M, Huber S, Sette A, Lütgehetmann M, Pischke S, Kwok W, Sidney J, Schulze Zur Wiesch J
FRONT IMMUNOL. 2023;14:.

Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis
Wolski A, Pischke S, Ozga A, Addo M, Horvatits T
PATHOGENS. 2023;12(3):425.

Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
Woo M, Brehm T, Fischer M, Heyer A, Wichmann D, Jordan S, Nörz D, Lütgehetmann M, Addo M, Lohse A, Schmiedel S, Kluge S, Schulze Zur Wiesch J
MICROBIOL SPECTR. 2023;11(1):.

Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections
Woo M, Mayer C, Brehm T, Andersen G, Weigel A, Löwe B, Lohse A, Addo M, Gerloff C, Knobloch J, Schulze Zur Wiesch J, Friese M
BRAIN COMMUN. 2023;5(2):fcad092.

Vagus nerve inflammation contributes to dysautonomia in COVID-19
Woo M, Shafiq M, Fitzek A, Dottermusch M, Altmeppen H, Mohammadi B, Mayer C, Bal L, Raich L, Matschke J, Krasemann S, Pfefferle S, Brehm T, Lütgehetmann M, Schädler J, Addo M, Schulze Zur Wiesch J, Ondruschka B, Friese M, Glatzel M
ACTA NEUROPATHOL. 2023;146(3):387-394.

Notfallimpfstoffe: Wie sieht die Zukunft aus?
Addo M
2022. Infektionen und Gesellschaft. Lohse A, Mettenleiter T (eds.). 1. ed. Berlin, Heidelberg: Springer Spektrum, Berlin, Heidelberg, 68-71.

Reisemedizin nimmt wieder an Fahrt auf!
Addo M
DEUT MED WOCHENSCHR. 2022;147(12):729-730.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
Amuge P, Lugemwa A, Wynne B, Mujuru H, Violari A, Kityo C, Archary M, Variava E, White E, Turner R, Shakeshaft C, Ali S, Nathoo K, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa A, Giaquinto C, Rojo P, Gibb D, Turkova A, Ford D
LANCET HIV. 2022;9(9):e638-e648.

Recommendations regarding screening, diagnosis, treatment, and clinical management of Chagas disease in Germany: AWMF-Register-Nr. 042-009
Bissinger A, Deneke T, Feldt T, Froeschl G, Gálvez R, Guertler L, Hoerauf A, Hübner M, Jacobs T, Jochum J, Kobbe R, Leuschner F, Pritsch M, Ramharter M, Richter J, Rieke B, Schmiedel S, Seeba H, Stich A, Strauss R, Weinauer F, Weizsäcker K, Wirth M, Zoller T
2022.

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
Brehm T, Pfefferle S, von Possel R, Karolyi M, Zoufaly A, Wichmann D, Kobbe R, Emmerich P, Nörz D, Aepfelbacher M, Schulze Zur Wiesch J, Addo M, Schmiedel S, Lütgehetmann M
J MED VIROL. 2022;94(10):5038-5043.

Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers
Brehm T, Ullrich F, Thompson M, Küchen J, Schwinge D, Spier A, Huber S, Knobloch J, Aepfelbacher M, Addo M, Lohse A, Lütgehetmann M, Schulze Zur Wiesch J
VACCINES-BASEL. 2022;10(7):.

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
Fathi A, Dahlke C, Krähling V, Kupke A, Okba N, Raadsen M, Heidepriem J, Müller M, Paris G, Lassen-Haartje S, Klüver M, Volz A, Koch T, Ly M, Friedrich M, Fux R, Tscherne A, Kalodimou G, Schmiedel S, Corman V, Hesterkamp T, Drosten C, Loeffler F, Haagmans B, Sutter G, Becker S, Addo M
NAT COMMUN. 2022;13(1):4182.

Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50
Fliegauf M, Kinnunen M, Posadas-Cantera S, Camacho-Ordonez N, Abolhassani H, Alsina L, Atschekzei F, Bogaert D, Burns S, Church J, Dückers G, Freeman A, Hammarström L, Hanitsch L, Kerre T, Kobbe R, Sharapova S, Siepermann K, Speckmann C, Steiner S, Verma N, Walter J, Westermann-Clark E, Goldacker S, Warnatz K, Varjosalo M, Grimbacher B
FRONT IMMUNOL. 2022;13:.

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
Gonçalves B, Hall M, Jassat W, Balan V, Murthy S, Kartsonaki C, Semple M, Rojek A, Baruch J, Reyes L, Dasgupta A, Dunning J, Citarella B, Pritchard M, Martín-Quiros A, Sili U, Baillie J, Aryal D, Arabi Y, Rashan A, Angheben A, Caoili J, Carrier F, Harrison E, Gómez-Junyent J, Figueiredo-Mello C, Douglas J, Mat Nor M, Chow Y, Wong X, Bertagnolio S, Thwin S, Streinu-Cercel A, Salazar L, Rishu A, Rangappa R, Ong D, Hashmi M, Carson G, Diaz J, Fowler R, Kraemer M, Wils E, Horby P, Merson L, Olliaro P
ELIFE. 2022;11:.

Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients
Hagemann K, Riecken K, Jung J, Hildebrandt H, Menzel S, Bunders M, Fehse B, Koch-Nolte F, Heinrich F, Peine S, Schulze Zur Wiesch J, Brehm T, Addo M, Lütgehetmann M, Altfeld M
EUR J IMMUNOL. 2022;52(8):1297-1307.

Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
Harberts A, Schaub G, Ruether D, Duengelhoef P, Brehm T, Karsten H, Fathi A, Jahnke-Triankowski J, Fischer L, Addo M, Haag F, Lütgehetmann M, Lohse A, Schulze zur Wiesch J, Sterneck M
CLIN GASTROENTEROL H. 2022;20(11):2558-2566.e5.

Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
Heyer A, Günther T, Robitaille A, Lütgehetmann M, Addo M, Jarczak D, Kluge S, Aepfelbacher M, Schulze Zur Wiesch J, Fischer N, Grundhoff A
CELL REP MED. 2022;3(9):.

Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2
Hotop S, Reimering S, Shekhar A, Asgari E, Beutling U, Dahlke C, Fathi A, Khan F, Lütgehetmann M, Ballmann R, Gerstner A, Tegge W, Cicin-Sain L, Bilitewski U, McHardy A, Brönstrup M
EMERG MICROBES INFEC. 2022;11(1):1037-1048.

Die COVID-19-Pandemie – ein epochales Ereignis
Janssens U, Addo M, von Bergwelt-Baildon M
DEUT MED WOCHENSCHR. 2022;147(20):1297-1298.

Erratum: Die COVID-19-Pandemie – ein epochales Ereignis
Janssens U, Addo M, von Bergwelt-Baildon M
DEUT MED WOCHENSCHR. 2022;147(20):e114.

Eine Erhebung zum Impfstatus von COVID-19-Patienten auf Normal- und Intensivstationen in Hamburg
Kluge S, Jarczak D, Eberhardt R, Herrlinger K, Janneck M, Borlich O, Weber C, Schley J, Emami P, Bergmann M, Addo M, Kerner T
DEUT MED WOCHENSCHR. 2022;147(8):492-494.

Vertical anti-SARS-CoV-2 monoclonal antibody transfer from mothers to HIV-exposed and unexposed infants
Kobbe R, Schulze-Sturm U, Kurnaz P, Rau C, Tallarek A, Lütgehetmann M, Jordan S, Schmiedel S
AIDS. 2022;36(11):1613-1615.

Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients
Koll C, Hopff S, Meurers T, Lee C, Kohls M, Stellbrink C, Thibeault C, Reinke L, Steinbrecher S, Schreiber S, Mitrov L, Frank S, Miljukov O, Erber J, Hellmuth J, Reese J, Steinbeis F, Bahmer T, Hagen M, Meybohm P, Hansch S, Vadász I, Krist L, Jiru-Hillmann S, Prasser F, Vehreschild J
SCI DATA. 2022;9(1):.

Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity
Marwali E, Kekalih A, Yuliarto S, Wati D, Rayhan M, Valerie I, Cho H, Jassat W, Blumberg L, Masha M, Semple C, Swann O, Kohns Vasconcelos M, Popielska J, Murthy S, Fowler R, Guerguerian A, Streinu-Cercel A, Pathmanathan M, Rojek A, Kartsonaki C, Gonçalves B, Citarella B, Merson L, Olliaro P, Dalton H
BMJ PAEDIATR OPEN. 2022;6(1):.

Debunking Misinformation and Communicating Critical Events in Vaccine Trials: Experimental Evidence on Vaccination Intentions in SARS-CoV-2 Pandemic
Memenga P, Eitze S, Shamsrizi P, Addo M, Betsch C
European Journal of Health Communication. 2022;3(2):64-96.

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
Meyer Zu Natrup C, Tscherne A, Dahlke C, Ciurkiewicz M, Shin D, Fathi A, Rohde C, Kalodimou G, Halwe S, Limpinsel L, Schwarz J, Klug M, Esen M, Schneiderhan-Marra N, Dulovic A, Kupke A, Brosinski K, Clever S, Schünemann L, Beythien G, Armando F, Mayer L, Weskamm L, Jany S, Freudenstein A, Tuchel T, Baumgärtner W, Kremsner P, Fendel R, Addo M, Becker S, Sutter G, Volz A
J CLIN INVEST. 2022;132(24):.

Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus
Nörz D, Brehm T, Tang H, Grewe I, Hermanussen L, Matthews H, Pestel J, Degen O, Günther T, Grundhoff A, Fischer N, Addo M, Jordan S, Hertling S, Unger S, Schäfer G, Schewe K, Hoffmann C, Aepfelbacher M, Pfefferle S, Schulze Zur Wiesch J, Schmiedel S, Lütgehetmann M
J CLIN VIROL. 2022;155:.

Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022
Nörz D, Pfefferle S, Brehm T, Franke G, Grewe I, Knobling B, Aepfelbacher M, Huber S, Klupp E, Jordan S, Addo M, Schulze Zur Wiesch J, Schmiedel S, Lütgehetmann M, Knobloch J
EUROSURVEILLANCE. 2022;27(26):.

Rapid Adaptation of Established High-Throughput Molecular Testing Infrastructure for Monkeypox Virus Detection
Nörz D, Tang H, Emmerich P, Giersch K, Fischer N, Schmiedel S, Addo M, Aepfelbacher M, Pfefferle S, Lütgehetmann M
EMERG INFECT DIS. 2022;28(9):1765-1769.

The effects of SARS-CoV-2 virus type and of vaccination status on causes of death over the course of the COVID-19 pandemic
Paparoupa M, Schröder A, Braunsteiner J, Addo M, Lütgehetmann M, Roedl K, Kluge S, Ondruschka B, Wichmann D
DTSCH ARZTEBL INT. 2022;119(35-36):607-608.

Aktualisierte Empfehlungen zur infektiologischen Versorgung von Flüchtlingen im Kindes- und Jugendalter in Deutschland (Stand 30. März 2022), angemeldet als S1-Leitlinie (AWMF-Register Nr. 048-017): Stellungnahme der Deutschen Gesellschaft für Pädiatrische Infektiologie e. V. (DGPI), der Gesellschaft für Tropenpädiatrie und Internationale Kindergesundheit e. V. (GTP), des Berufsverbandes der Kinder- und Jugendärzte e. V. (BVKJ) und der Deutschen Gesellschaft für Kinder- und Jugendmedizin e. V. (DGKJ), unter Mitarbeit des Berufsverbands der Ärztinnen und Ärzte des Öffentlichen Gesundheitsdienstes e. V. (BVÖGD), der Deutschen Gesellschaft für Kinderchirurgie e. V. (DGKCH), der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG), Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM), des Bündnis Kinder- und Jugendgesundheit e. V. (früher Deutsche Akademie für Kinder- und Jugendmedizin, DAKJ), der Deutschen Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit e. V. (DTG), der Deutschen Gesellschaft für Globale und Tropenchirurgie e. V. (DTC) und der Pädiatrisch Infektiologischen Gruppe Schweiz (PIGS)
Pfeil J, Assaad K, von Both U, Janda A, Kitz C, Kobbe R, Kunze M, Lindert J, Ritz N, Trapp S, Hufnagel M
MONATSSCHR KINDERH. 2022;170(7):632-647.

Data quality of reported child immunization coverage in 194 countries between 2000 and 2019.
Rau C, Lüdecke D, Dumolard L, Grevendonk J, Wiernik B, Kobbe R, Gacic-Dobo M, Danovaro-Holliday M
PLOS Global Public Health. 2022;2(2):e0000140.

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
Reyes L, Murthy S, Garcia-Gallo E, Merson L, Ibáñez-Prada E, Rello J, Fuentes Y, Martin-Loeches I, Bozza F, Duque S, Taccone F, Fowler R, Kartsonaki C, Gonçalves B, Citarella B, Aryal D, Burhan E, Cummings M, Delmas C, Diaz R, Figueiredo-Mello C, Hashmi M, Panda P, Jiménez M, Rincon D, Thomson D, Nichol A, Marshall J, Olliaro P
CRIT CARE. 2022;26(1):276.

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Santamaria M, Neth O, Douglass J, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón S, Langguth D, Gonzalez-Granado L, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A, Lin J
J CLIN IMMUNOL. 2022;42(3):512-513.

The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
Schons M, Pilgram L, Reese J, Stecher M, Anton G, Appel K, Bahmer T, Bartschke A, Bellinghausen C, Bernemann I, Brechtel M, Brinkmann F, Brünn C, Dhillon C, Fiessler C, Geisler R, Hamelmann E, Hansch S, Hanses F, Hanß S, Herold S, Heyder R, Hofmann A, Hopff S, Horn A, Jakob C, Jiru-Hillmann S, Keil T, Khodamoradi Y, Kohls M, Kraus M, Krefting D, Kunze S, Kurth F, Lieb W, Lippert L, Lorbeer R, Lorenz-Depiereux B, Maetzler C, Miljukov O, Nauck M, Pape D, Püntmann V, Reinke L, Römmele C, Rudolph S, Sass J, Schäfer C, Schaller J, Schattschneider M, Scheer C, Scherer M, Schmidt S, Schmidt J, Seibel K, Stahl D, Steinbeis F, Störk S, Tauchert M, Tebbe J, Thibeault C, Toepfner N, Ungethüm K, Vadasz I, Valentin H, Wiedmann S, Zoller T, Nagel E, Krawczak M, von Kalle C, Illig T, Schreiber S, Witzenrath M, Heuschmann P, Vehreschild J
EUR J EPIDEMIOL. 2022;37(8):849-870.

Therapeutic Management of COVID-19 in a Pediatric Patient with Neurodegenerative CLN2 Disease and ICV-Enzyme Replacement Therapy: A Case Report
Schwering C, Apostolidou S, Deindl P, Christner M, Knobloch J, Herrmann J, Kobbe R, Schulz A, Singer D, Ebenebe C
NEUROPEDIATRICS. 2022;53(5):381-384.

Infektiologische Versorgung minderjähriger Flüchtlinge am Beispiel der Ukraine: Vorgehen in Deutschland gemäß der S1-Leitlinine (AWMF-Register Nr. 048-017)
Spielberger B, Pfeil J, Assaad K, von Both U, Janda A, Kitz C, Kobbe R, Kunze M, Lindert J, Ritz N, Trapp S, Hufnagel M
MONATSSCHR KINDERH. 2022;170(12):1103-1112.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Turkova A, Waalewijn H, Chan M, Bollen P, Bwakura-Dangarembizi M, Kekitiinwa A, Cotton M, Lugemwa A, Variava E, Ahimbisibwe G, Srirompotong U, Mumbiro V, Amuge P, Zuidewind P, Ali S, Kityo C, Archary M, Ferrand R, Violari A, Gibb D, Burger D, Ford D, Colbers A
LANCET HIV. 2022;9(9):E627-E637.

Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens
Weskamm L, Dahlke C, Addo M
STAR PROTOC. 2022;3(4):.

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
Weskamm L, Fathi A, Raadsen M, Mykytyn A, Koch T, Spohn M, Friedrich M, , Haagmans B, Becker S, Sutter G, Dahlke C, Addo M
CELL REP MED. 2022;3(7):.

The value of open-source clinical science in pandemic response: lessons from ISARIC

LANCET INFECT DIS. 2021;21(12):1623-1624.

Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
Hall M, Baruch J, Carson G, Citarella B, Dagens A, Dankwa E, Donnelly C, Dunning J, Escher M, Kartsonaki C, Merson L, Pritchard M, Wei J, Horby P, Rojek A, Olliaro P
ELIFE. 2021;10:.

Infektionen und Gesellschaft
Lohse A, Addo M
2021. Infektionen und Gesellschaft. Lohse A (eds.). 1. ed. Hamburg: Springer, 3-4; 135-147.

COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a+
Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert F, Hölzer B, Skrzypczyk S, Kohut E, Kurek J, Zapka J, Wehler P, Kaliszczyk S, Bajda S, Thieme C, Roch T, Konik M, Berger M, Brenner T, Kölsch U, Meister T, Pfaender S, Steinmann E, Tempfer C, Watzl C, Dolff S, Dittmer U, Abou-El-Enein M, Westhoff T, Witzke O, Stervbo U, Babel N
MOL THER. 2020;28(12):2691-2702.

Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient
Babel N, Anft M, Blazquez-Navarro A, Doevelaar A, Seibert F, Bauer F, Rohn B, Hoelzer B, Thieme C, Roch T, Meister T, Pfaender S, Steinmann E, Dittmer U, Schenker P, Amann K, Viebahn R, Stervbo U, Westhoff T
AM J TRANSPLANT. 2020;20(11):3210-3215.

Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2
Meister T, Brüggemann Y, Todt D, Conzelmann C, Müller J, Groß R, Münch J, Krawczyk A, Steinmann J, Steinmann J, Pfaender S, Steinmann E
J INFECT DIS. 2020;222(8):1289-1292.

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Meister T, Klöhn M, Steinmann E, Todt D
JOVE-J VIS EXP. 2020;(160):.

Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2
Steinhauer K, Meister T, Todt D, Krawczyk A, Paßvogel L, Becker B, Paulmann D, Bischoff B, Eggers M, Pfaender S, Brill F, Steinmann E
J HOSP INFECT. 2020.

Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
Thieme C, Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert F, Hoelzer B, Konik M, Berger M, Brenner T, Tempfer C, Watzl C, Meister T, Pfaender S, Steinmann E, Dolff S, Dittmer U, Westhoff T, Witzke O, Stervbo U, Roch T, Babel N
CELL REP MED. 2020;1(6):100092.

Robust hepatitis E virus infection and transcriptional response in human hepatocytes
Todt D, Friesland M, Moeller N, Praditya D, Kinast V, Brüggemann Y, Knegendorf L, Burkard T, Steinmann J, Burm R, Verhoye L, Wahid A, Meister T, Engelmann M, Pfankuche V, Puff C, Vondran F, Baumgärtner W, Meuleman P, Behrendt P, Steinmann E
P NATL ACAD SCI USA. 2020;117(3):1731-1741.

Evaluation of vector-specific immune responses following a homologous prime boost immunization with the vaccine candidate MVA-MERS-S
Weichel H
2020.

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
Zettl F, Meister T, Vollmer T, Fischer B, Steinmann J, Krawczyk A, V’kovski P, Todt D, Steinmann E, Pfaender S, Zimmer G
VACCINES-BASEL. 2020.

Cell culture systems for the study of hepatitis E virus
Meister T, Bruening J, Todt D, Steinmann E
ANTIVIR RES. 2019.

Characterization of Equine Parvovirus in Thoroughbred Breeding Horses from Germany
Meister T, Tegtmeyer B, Brüggemann Y, Sieme H, Feige K, Todt D, Stang A, Cavalleri J, Steinmann E
VIRUSES-BASEL. 2019;11(10):.

Equine Parvovirus-Hepatitis Frequently Detectable in Commercial Equine Serum Pools
Meister T, Tegtmeyer B, Postel A, Cavalleri J, Todt D, Stang A, Steinmann E
VIRUSES-BASEL. 2019;11(5):.

PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment
Reinink H, de Jonge J, Bath P, van de Beek D, Berge E, Borregaard S, Ciccone A, Csiba L, Demotes J, Dippel D, Kõrv J, Kurkowska-Jastrzebska I, Lees K, Macleod M, Ntaios G, Randall G, Thomalla G, van der Worp H
EUR STROKE J. 2018;3(3):291-298.

Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse
Todt D, Meister T, Steinmann E
CURR OPIN VIROL. 2018;32:80-87.

Letzte Aktualisierung aus dem FIS: 23.01.2026 - 04:32 Uhr